The 12 most recent market catalysts affecting $OGI, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Nov 3, 2026
Corporate Catalyst
Bullish
Impact 95
Organigram Global Agrees to Acquire Aurora Cannabis, Ending Curaleaf's Hostile Takeover Bid
Organigram Global announced its agreement to acquire Aurora Cannabis for C$561 million, effectively ending Curaleaf Holdings' hostile takeover efforts. This is a major M&A event in…
Nov 3, 2026
Corporate Catalyst
Bullish
Impact 75
British American Tobacco Provides Financing for Organigram-Aurora Cannabis Merger
British American Tobacco (BTI) is acting as a strategic investor, providing a £100 million financing commitment to support the merger of Organigram (OGI) and Aurora Cannabis (ACB).…
Nov 3, 2026
Corporate Catalyst
Bearish
Impact 75
Canadian Investment Regulatory Organization Implements Trading Halt on Organigram Global Inc.
The Canadian Investment Regulatory Organization (CIRO) has halted trading in Organigram Global Inc. (OGI) securities, citing 'Pending News.' This action is taken to ensure fair and…
Aug 25, 2026
Corporate Catalyst
Neutral
Impact 55
Osisko Gold Group Says Alexander Dann To Retire And Step Down As CFO; Elijah Tyshynski To Be Appointed As CFO
The retirement of a CFO and the appointment of a successor is a common corporate event. While it introduces a period of transition and potential shifts in financial strategy, it's …
Aug 20, 2026
Corporate Catalyst
Neutral
Impact 75
Organigram Global Accelerates Integration Of Sanity Group And Aligns Leadership, Operations And Market Development Activities
Organigram is formalizing the integration of its acquired Sanity Group, a key step in its global growth strategy. This matters because Sanity Group is a substantial contributor to …
Aug 11, 2026
Corporate Catalyst
Bullish
Impact 75
Organigram Global shares are trading higher after the company reported better-than-expected Q3 sales results and issued strong FY26 revenue guidance.
This headline represents a significant positive corporate catalyst for Organigram Global. The better-than-expected Q3 sales indicate strong operational performance in the short ter…
Aug 11, 2026
Corporate Catalyst
Bullish
Impact 75
OrganiGram Holdings Q3 Sales $76.413M Beat $67.660M Estimate
OrganiGram Holdings announced Q3 sales of $76.413 million, surpassing the analyst consensus of $67.660 million by 12.94%. This represents a significant 49.41% increase compared to …
Aug 11, 2026
Corporate Catalyst
Neutral
Impact 75
Organigram Affirm Global FY2026 Revenue expected to be more than $255.197M vs $241.360M Est
Organigram Global (OGI) has affirmed its FY2026 revenue guidance, stating it expects to exceed $255.197 million, which is notably higher than the analyst consensus of $241.360 mill…
Jul 20, 2026
Corporate Catalyst
Bullish
Impact 65
Organigram Maintains Cannabis Market Lead Ahead Of Q3 Results
Organigram (OGI) issued a business update ahead of its Q3 Fiscal 2026 results, which will be the first to include consolidated financials from its acquisition of Sanity Group. The …
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.